• 2023

  • Focussed Assessment with Sonography in acute Lassa Fever (FASLa): Development of a point-of-care protocol and description of common ultrasound findings

    • Erameh CO, Koch T, Edeawe OI, Oestereich L, Omansen T, Jochum J, Adomeh DI, Ikponmwonsa O, Aire C, Pahlmann M, Asogun DA, Ogbaini-Emovon E, Okogbenin SA, Günther S, Ramharter M, Akideno PE, Kreuels B
    • J Infect. 2023 Jul;87(1):27-33. doi: 10.1016/j.jinf.2023.04.008
    • 2023-04-17

• 2022

  • Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections

    • Okogbenin S, Erameh C, Okoeguale J, Osahogie E, Ekuaze E, Iraoyah K, Agho J, Groger M, Kreuels B, Oestereich L, Babatunde FO, Akhideno P, Günther S, Ramharter M, Omansen T
    • Emerg Infect Dis. 2022 Oct;28(10):2060-2063. doi: 10.3201/eid2810.220625
    • 2022-10-28

• 2021

  • Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer

    • Komm O, Almeida DV, Converse PJ, Omansen TF, Nuermberger EL
    • Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0141821. doi: 10.1128/AAC.01418-21
    • 2021-08-30

• 2020

  • Relapsing cutaneous leishmaniasis in a patient requiring TNF-α-inhibitor Infliximab for Takayasu-arteritis: Case report and review of the literature

    • Heinemann M, Omansen TF, Hennigs A, Völker K, Menz A, Addo MM, Schmiedel S
    • Travel Med Infect Dis. 2020 Sep-Oct;37:101700. doi: 10.1016/j.tmaid.2020.101700
    • 2020-04-25

  • Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria

    • Erameh C, Edeawe O, Akhideno P, Eifediyi G, Omansen TF, Wagner C, Sarpong F, Koch T, Wicha S, Kurth F, Duraffour S, Oestereich L, Pahlmann M, Okogbenin S, Ogbaini-Emovon E, Günther S, Ramharter M, Groger M
    • BMJ Open. 2020 Apr 16;10(4):e036936. doi: 10.1136/bmjopen-2020-036936
    • 2020-04-16